Skip to main content
    M

    Mirum Pharmaceuticals Inc (MIRM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $91.95
    +0.37 (+0.40%)

    Market Cap: $5.98B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Mirum Pharmaceuticals Inc (MIRM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Mirum Pharmaceuticals (MIRM) has a latest price of $91.95 on Nov 17, 2026, 29.3% below its 52-week high of $130.00. Its price rose 28.7% over the past 12 months. The month-end price rose 435.3% over the 5 years through Oct 2026, a compound annual rate of 39.9%.

    Price Chart

    From Jul 2019 to Oct 2026, its highest month-end close was $117.07 in Jun 2026 and its lowest $7.18 in Oct 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MIRM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MIRM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 10.1%, and over 6 months it fell 3.9%. The month-end price rose 209.9% over the 3 years through Oct 2026, a compound annual rate of 45.8%.

    PeriodChange
    1 month+11.8%
    3 months-10.1%
    6 months-3.9%
    12 months+28.7%
    12 months, with dividends+28.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+209.9%+45.8%
    5 years+435.3%+39.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 91.0%, and its weakest was 2020, when it fell 28.8%.

    YearCloseChange
    2026 through Oct 2026$85.00+7.6%
    2025$78.99+91.0%
    2024$41.35+40.1%
    2023$29.52+51.4%
    2022$19.50+22.3%
    2021$15.95-8.6%
    2020$17.46-28.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.0% above its 50-day average of $88.45 and 6.5% below its 200-day average of $98.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$91.95
    52-week high$130.00-29.3%
    52-week low$63.23+45.4%
    50-day average$88.45+4.0%
    200-day average$98.29-6.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 38.4%.

    MeasureValue
    1-year beta1.08
    Largest fall, 1 year-38.4%
    Largest fall, 3 years-38.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MIRM

    What is MIRM's 1-year price change?

    Mirum Pharmaceuticals's price rose 28.7% over the past 12 months. With dividends included, the 12-month total return was 28.7%.

    What is MIRM's 5-year price change?

    Mirum Pharmaceuticals's month-end price rose 435.3% over the 5 years through Oct 2026, a compound annual rate of 39.9%. These figures leave out dividends.

    What is MIRM's 52-week high and low?

    Mirum Pharmaceuticals's 52-week high is $130.00 and its 52-week low is $63.23. Its latest price of $91.95 on Nov 17, 2026 is 29.3% below the high.

    What is MIRM's beta?

    Mirum Pharmaceuticals's 1-year beta against the S&P 500 is 1.08, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 38.4%.

    Is the MIRM chart free?

    Yes. Advanced Charting for MIRM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.